Riassunto
Il mioclono costituisce un particolare disordine del movimento che può derivare da diversi generatori del sistema nervoso, avere modalità di comparsa variabile ed eziologie eterogenee.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliografia
Marsden CD, Hallett M, Fahn S. The nosology and pathophysiology of myoclonus. Mov Disord 1982:196–248.
Fahn S, Marsden CD, Van Woert MH. Definition and classification of myoclonus. Adv Neurol 1986; 43:1–5.
Nirenberg MJ, Frucht SJ. Myoclonus. Curr Treat Options Neurol 2005; 7:221–230.
Prasad A, Kuzniecky RI, Knowlton RC, Welty TE, Martin RC, Mendez M, Faught RE. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. Arch Neurol. 2003; 60:1100–1105.
Shahwan A, Farrell M, Delanty N: Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol 2005; 4:239–248.
Kalviainen R, Khyuppenen J, Koskenkorva P et al. Clinical picture of EPM1-Unverricht-Lundborg disease. Epilepsia 2008; 49:549–556.
Genton P, Gelisse P, Crespel A. Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease. Epilepsia 2006; 47 (12):2083–2085.
Aykutlu E, Baykan B, Gurses C et al. Add-on therapy with topiramate in progressive myoclonic epilepsy. Epilepsy Behav 2005; 6:260–263.
Noachtar S, Andermann E, Meyvisch P et al. N166 Levetiracetam Study Group. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 2008; 70:607–616.
Magaudda A, Gelisse P, Genton P. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations. Epilepsia 2004; 45:678–681.
Kothare SV, Valencia I, Khurana DS et al. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Epileptic Disord 2004; 6:267–270.
Henry TR, Leppik IE, Gumnit RJ et al. Progressive myoclonus epilepsy treated with zonisamide. Neurology 1988; 38:928–931.
Koskiniemi M, Van Vleymen B, Hakamies L et al. Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo. J Neurol Neurosurg Psychiatry 1998; 64:344–348.
Uthman BM, Reichl A. Progressive Myoclonic Epilepsies. Curr Treat Options Neurol 2002; 4:3–17.
Frucht SJ. The clinical challenge of posthypoxic myoclonus. Adv Neurol 2002; 89:85–88.
Frucht SJ, Bordelon Y, Houghton WH et al. A pilot tolerability and efficacy trial of sodium oxybate in ethanolresponsive movement disorders. Mov Disord 2005; 20:1330–1337.
Deuschl G, Wilms H. Palatal tremor: the clinical spectrum and physiology of a rhythmic movement Disorder. Adv Neurol 2002; 89:115–130.
Nasr A, Brown N. Palatal myoclonus responding to lamotrigine. Seizure 2002; 11(2):136–137.
Penney SE, Bruce IA, Saeed SR. Botulinum toxin is effective and safe for palatal tremor: a report of five cases and a review of the literature. J Neurol 2006; 253:857–860.
Pranzatelli MR. The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 1996; 19:1–47.
Glatz K, Meinck HM, Wildemann B. Parainfectious opsoclonus-myoclonus syndrome: high-dose intravenous immunoglobulins are effective. J Neurol Neurosurg Psychiatry 2003; 74:279–280.
Yiu VW, Kovithavongs T, McGonigle LF et al. Plasmapheresis as an effective treatment for opsoclonusmyoclonus syndrome. Pediatr Neurol. 2001; 24:72–74.
Doria Lamba L, Giribaldi G, De Negri E et al. A case of major form familial hyperekplexia: prenatal diagnosis and effective treatment with clonazepam. J Child Neurol 2007; 22:769–772.
Chang VC, Frucht SJ. Myoclonus. Curr Treat Options Neurol. 2008; 10:222–229.
Cif L, Valente EM, Hemm S et al. Deep brain stimulation in myoclonus-dystonia syndrome. Mov Disord. 2004; 19:724–727.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Italia
About this chapter
Cite this chapter
Canafoglia, L., Granata, T., Franceschetti, S. (2009). Mioclono. In: Terapia delle malattie neurologiche. Springer, Milano. https://doi.org/10.1007/978-88-470-1120-5_17
Download citation
DOI: https://doi.org/10.1007/978-88-470-1120-5_17
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1119-9
Online ISBN: 978-88-470-1120-5
eBook Packages: MedicineMedicine (R0)